PubRank

D Adorno

Author PubWeight™ 29.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother 1996 1.32
2 Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation 2001 0.98
3 Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer. Cancer Immunol Immunother 2000 0.93
4 CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. Blood 2001 0.88
5 Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations. Cancer Immunol Immunother 1994 0.87
6 Bcl-2 and drugs used in the treatment of cancer: new strategies of biotherapy which should not be underestimated. Cancer Biother Radiopharm 1998 0.87
7 Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing. Tissue Antigens 2004 0.86
8 Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunother 1999 0.85
9 The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back. Cancer Immunol Immunother 1998 0.85
10 Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons. Exp Neurol 1996 0.80
11 Correlation between genetic HLA class I and II polymorphisms and anthropological aspects in the Chaouya population from Morocco (Arabic speaking). Tissue Antigens 2010 0.80
12 The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments. Cancer Biother Radiopharm 2000 0.80
13 Immunosorbent treatment in myasthenia gravis. Prog Clin Biol Res 1990 0.80
14 Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release. Neuroimmunomodulation 1998 0.79
15 Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. Int J Immunopathol Pharmacol 2010 0.79
16 IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer. Cancer Biother Radiopharm 1997 0.79
17 Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes. Diabetologia 1986 0.79
18 Flow cytometric analysis of antidonor-specific antibodies in liver transplant. Transplant Proc 1997 0.79
19 HLA antigens and neuroleptic response in clinical subtypes of schizophrenia. J Psychiatr Res 1989 0.78
20 Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm 1996 0.78
21 Renal allograft immune response is influenced by patient and donor cytokine genotypes. Transplant Proc 2007 0.78
22 HLA antigens and infantile psoriasis. Acta Derm Venereol Suppl (Stockh) 1989 0.78
23 Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. Cancer Biother Radiopharm 1999 0.77
24 Cytokine levels in amniotic fluid: a marker of preterm labor? Clin Exp Obstet Gynecol 2006 0.77
25 Inhibitory effects of gangliosides and cyclosporine on lymphocyte activation: analysis of cytokine gene mRNA transcripts. Transplant Proc 1993 0.77
26 CD1a and CD1e allele frequencies in an Italian population from the Abruzzo region. Int J Immunopathol Pharmacol 2007 0.77
27 Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats. Drugs Exp Clin Res 1991 0.77
28 HLA-B14 antigen in cluster headache. Headache 1984 0.76
29 Genetic markers of cluster headache and the links with the lithium salts therapy. Int J Clin Pharmacol Res 1986 0.76
30 Identification of the novel HLA-A*9250 allele by sequence-based typing in a Caucasian bone marrow donor from Italy. Tissue Antigens 2008 0.76
31 Identification of a novel HLA-B allele, HLA-B*3580, with possible implication in transplantation and CTL response. Tissue Antigens 2007 0.76
32 Sequence-based typing characterization of the novel HLA-Cw*1609 allele in the Moroccan Chaouya group. Tissue Antigens 2007 0.76
33 B*3812: a new HLA-B38 variant identified by sequence-based typing. Tissue Antigens 2006 0.75
34 Identification of the very uncommon allele HLA-Cw*0716 in a Caucasian renal transplant recipient: extension of the exon 4 sequence. Tissue Antigens 2007 0.75
35 A new HLA-CW*14 allele, Cw*140204, identified by allele-specific DNA amplification and sequencing. Tissue Antigens 2006 0.75
36 A new HLA-A allele identified in a leukemic patient attending hematopoietic cell transplantation: A*2318. Tissue Antigens 2008 0.75
37 Identification of the uncommon allele HLA-A*7403 in a Caucasian renal transplant cadaveric donor: extension of the exon 4 sequence. Tissue Antigens 2007 0.75
38 Disease stage prognostic indices in the early clinical screening of colorectal cancer patients. Cancer Biother Radiopharm 1998 0.75
39 Elevated frequency of HLA shared-haplotypes in migraine families. Headache 1987 0.75
40 RT-PCR analysis of immune-modulating factors in PBMCs from patients with cancer: reduced IL-2 and increased IL-2-receptor (p55) expression characterize gastroenteric neoplasms. Anticancer Res 1999 0.75
41 Anti-HLA antibodies in kidney transplanted patients. Transplant Proc 2005 0.75
42 Microprotein kinetics in dialysis. Beta-2-microglobulin and heparin-free hemodialysis. Contrib Nephrol 1989 0.75
43 Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome. Transplant Proc 2001 0.75
44 HLA class I residue mismatch and renal graft outcome. Transpl Int 2000 0.75
45 [Specific antibodies against lymphocytes and monocytes in multiple-transfused uremic patients]. Boll Soc Ital Biol Sper 1983 0.75
46 [Preliminary considerations on the occurrence of antigens of the HLA system in a group of chronic glomerulonephritis patients]. Boll Soc Ital Biol Sper 1981 0.75
47 [HLA and renal diseases]. Minerva Med 1982 0.75
48 Cytokine contribution to the repair processes and homeostasis recovery following anoxic insult: a possible IFN-gamma-regulating role in IL-1beta neurotoxic action in physiological or damaged CNS. Neuroimmunomodulation 1997 0.75
49 Hemodialysis patients waiting for a kidney transplant: immunologic investigation. Transplant Proc 1979 0.75
50 Identification of a novel HLA-DRB1*11 allele: DRB1*1152. Tissue Antigens 2006 0.75
51 Low responsiveness to Candida antigens in kidney transplant recipients. Microbiologica 1991 0.75
52 Flow cytometry crossmatch: a sensitive technique for assessment of acute rejection in renal transplantation. Transplant Proc 1998 0.75
53 [Genetic and immunoneuromodulatory aspects in hemicrania]. Ann Ital Med Int 1990 0.75
54 Identification of the novel allele B*4427 and a confirmatory sequence (B*44022). Tissue Antigens 2002 0.75
55 Transplant organization in Italy. Transplant Proc 1992 0.75
56 [Separation of monocytes and their use in a cytotoxicity test]. Boll Soc Ital Biol Sper 1983 0.75
57 [Heart transplantation: the role of histocompatibility]. Minerva Chir 1992 0.75
58 Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation. Transplant Proc 1979 0.75
59 Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer. Cancer Biother Radiopharm 1996 0.75
60 Plasma perfusion in myasthenia gravis. ASAIO Trans 1989 0.75
61 Sequence analysis of a new HLA-DR11 allele in a Caucasian Italian family: DRB1*11272. Tissue Antigens 2000 0.75
62 The place of heart transplantation: the Italian experience. Eur Heart J 1987 0.75
63 Developing countries as the major future source of living donor renal transplants. Transplant Proc 1992 0.75
64 HLA sharing in couples with recurrent abortion. Exp Clin Immunogenet 1985 0.75
65 Hepatitis C virus infection in kidney transplant recipients. Transplant Proc 1993 0.75
66 Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat. II. Effects on corticostriatal transmission. Exp Neurol 1997 0.75
67 Extracorporeal blood recirculation and beta-2-microglobulin plasma levels during hemodialysis. ASAIO Trans 1989 0.75
68 Kidney transplant monitoring by anti donor specific antibodies. Transpl Int 1992 0.75
69 Posttransplant donor-specific antibody characterization and kidney graft survival. Transpl Int 2000 0.75
70 Treatment of thalassemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1993 0.75
71 Interleukin 1-beta modulates the effects of hypoxia in neuronal culture. J Neuroimmunol 2000 0.75
72 Flow cytometry crossmatching in donor/recipient selection. Transplant Proc 1991 0.75
73 Monitoring after transplantation in liver and kidney transplant recipients with anti-donor HLA antibodies. Transplant Proc 1993 0.75
74 [Immunologic monitoring in heart transplant]. Minerva Chir 1989 0.75
75 Gangliosides potentiate cyclosporine A-induced suppression of allospecific immune responses. Transplant Proc 1991 0.75
76 The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer. Cancer Biother Radiopharm 1997 0.75
77 T-lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity. Ital J Neurol Sci 1986 0.75
78 Flow cytometry crossmatch and kidney graft outcome. Transplant Proc 1999 0.75
79 Immunological directives for biotherapy improvement in the treatment of colorectal cancer. Cancer Biother Radiopharm 1996 0.75
80 Waiting list for kidney transplants. Transplant Proc 2005 0.75
81 Identification of factors interacting with a subset of T8+ cells. Riv Neurol 1987 0.75
82 Gangliosides potentiate the immunosuppressive effects of cyclosporin A in rat skin allografts. Transpl Int 1992 0.75
83 Identification of a novel HLA-A*02 allele, A*027401*. Tissue Antigens 2005 0.75
84 HLA typing data on 100 type 1 (insulin-dependent) diabetic patients from central Italy show a negative association with DR5 rather than with DR2. Clin Immunol Immunopathol 1987 0.75
85 Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules. Cancer Biother Radiopharm 2001 0.75
86 HLA-DR matching and graft survival in heart transplant. Transplant Proc 1990 0.75
87 Immunologic monitoring in kidney transplantation. Transplant Proc 1991 0.75
88 Improving screening strategies for HLA-specific antibody detection in renal transplant recipients. Transplant Proc 2001 0.75
89 Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant. Transplant Proc 1993 0.75
90 Subcutaneous administration of interleukin-2 triggers Fcgamma receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies. J Immunother 2001 0.75
91 Characterization of a novel HLA-Cw*02 variant, Cw*0208, in a Caucasian individual. Tissue Antigens 2005 0.75
92 Transfused and pharmacological iron: relationship of overload to HLA antigens. Proc Eur Dial Transplant Assoc 1983 0.75
93 HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients. Transplant Proc 1992 0.75
94 Early organ toxicity following allogeneic bone marrow transplantation in congenital hemopathies. Bone Marrow Transplant 1996 0.75
95 Unrelated living donor kidney transplant and developing countries. Transplant Proc 1992 0.75
96 [Alloantigens of subpopulations of T lymphocytes in uremic patients with chronic glomerulonephritis]. Minerva Nefrol 1982 0.75